Literature DB >> 10994019

Progression of Hoehn and Yahr stages in Parkinsonian disorders: a clinicopathologic study.

J Müller1, G K Wenning, K Jellinger, A McKee, W Poewe, I Litvan.   

Abstract

The progression to different Hoehn and Yahr (HY) stages was evaluated in 81 pathologically confirmed patients with parkinsonism. Patients with PD (n = 18) showed significantly longer latencies to each HY stage than patients with atypical parkinsonian disorder (APD). While no patient with PD developed a HY-III stage within 1 year of onset of motor symptoms, 72% of those with APDs did. In fact, development of a HY-III within 1 year of motor onset accurately predicted an APD. However, the progression to each HY stage was unhelpful in distinguishing the APDs from each other. Once patients with PD and APD became wheelchair-bound, both had equally short survival times.

Entities:  

Mesh:

Year:  2000        PMID: 10994019     DOI: 10.1212/wnl.55.6.888

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  22 in total

1.  Robust Bayesian hierarchical model using normal/independent distributions.

Authors:  Geng Chen; Sheng Luo
Journal:  Biom J       Date:  2015-12-29       Impact factor: 2.207

Review 2.  How to diagnose MSA early: the role of magnetic resonance imaging.

Authors:  K Seppi; M F H Schocke; G K Wenning; W Poewe
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

Review 3.  Epidemiology of Parkinson's disease.

Authors:  Guido Alves; Elin Bjelland Forsaa; Kenn Freddy Pedersen; Michaela Dreetz Gjerstad; Jan Petter Larsen
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

4.  Progression of parkinsonism in multiple system atrophy.

Authors:  Klaus Seppi; Farid Yekhlef; Anja Diem; Elisabeth Luginger Wolf; Joerg Mueller; François Tison; Niall P Quinn; Werner Poewe; Gregor K Wenning
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

Review 5.  Palliative Care for Parkinson's Spectrum Disorders: an Emerging Approach.

Authors:  Maya Katz
Journal:  Neurotherapeutics       Date:  2021-01-13       Impact factor: 7.620

6.  Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study.

Authors:  Carlo Colosimo; Letterio Morgante; Angelo Antonini; Paolo Barone; Tania P Avarello; Edo Bottacchi; Antonino Cannas; Maria Gabriella Ceravolo; Roberto Ceravolo; Giulio Cicarelli; Rosa M Gaglio; Luisa Giglia; Francesco Iemolo; Michela Manfredi; Giuseppe Meco; Alessandra Nicoletti; Massimo Pederzoli; Alfredo Petrone; Antonio Pisani; Francesco E Pontieri; Rocco Quatrale; Silvia Ramat; Rossana Scala; Giampiero Volpe; Salvatore Zappulla; Anna Rita Bentivoglio; Fabrizio Stocchi; Giorgio Trianni; Paolo Del Dotto; Lucia Simoni; Roberto Marconi
Journal:  J Neurol       Date:  2009-08-09       Impact factor: 4.849

7.  Bayesian Hierarchical Joint Modeling Using Skew-Normal/Independent Distributions.

Authors:  Geng Chen; Sheng Luo
Journal:  Commun Stat Simul Comput       Date:  2017-06-28       Impact factor: 1.118

8.  Progression of dopamine transporter decline in patients with the Parkinson variant of multiple system atrophy: a voxel-based analysis of [123I]β-CIT SPECT.

Authors:  Michael Nocker; Klaus Seppi; Eveline Donnemiller; Irene Virgolini; Gregor K Wenning; Werner Poewe; Christoph Scherfler
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-03-30       Impact factor: 9.236

9.  The Impact of Non-dopaminergic Medication on Quality of Life in Parkinson's Disease.

Authors:  Nicol G M Oonk; Kris L L Movig; Job van der Palen; Henk-Willem Nijmeijer; Mirjam E van Kesteren; Lucille D A Dorresteijn
Journal:  Clin Drug Investig       Date:  2021-08-10       Impact factor: 2.859

10.  Dopaminergic neurotoxins induce cell death by attenuating NF-κB-mediated regulation of TRPC1 expression and autophagy.

Authors:  Pramod Sukumaran; Yuyang Sun; Neil Antonson; Brij B Singh
Journal:  FASEB J       Date:  2018-01-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.